Table 2 Medical history and disease characteristics
Characteristic | Early responders n = 332 | Later responders n = 253 | Patients without Halm-based assessment of TCS n = 1454 |
|---|---|---|---|
Relevant medical conditions at hospitalization (initial visit*) (≥ 5% of analysis population), n (%) | |||
Any relevant condition | 255 (76.8) | 210 (83.0) | 1133 (77.9) |
Respiratory disease | 108 (32.5) | 90 (35.6) | 491 (33.8) |
Diabetes | 54 (16.3) | 52 (20.6) | 263 (18.1) |
Congestive heart disease | 48 (14.5) | 51 (20.2) | 237 (16.3) |
Cancer/malignancy | 30 (9.0) | 27 (10.7) | 180 (12.4) |
Peripheral vascular disease | 34 (10.2) | 23 (9.1) | 126 (8.7) |
Renal disease | 17 (5.1) | 20 (7.9) | 110 (7.6) |
Other relevant conditions† | 118 (35.5) | 102 (40.3) | 464 (31.9) |
Age of patients with comorbidities, years, mean (SD) [median] | 67.5 (17.2) [71] | 66.3 (17.92) [72] | 68.2 (16.4) [71] |
Age of patients without comorbidities, years, mean (SD) [median] | 51.9 (19.7) [49] | 55.5 (17.0) [54] | 52.4 (20.1) [50] |
Medication history in the 3 months prior to hospitalization, n (%) | |||
Any prior medication | 159 (47.5) | 148 (58.5) | 836 (57.5) |
Antibiotics/antivirals | 51 (15.4) | 52 (20.6) | 292 (20.1) |
Anticoagulants | 56 (16.9) | 39 (15.4) | 206 (14.2) |
Immunosuppressants/immunomodulators | 19 (5.7) | 19 (7.5) | 113 (7.8) |
Non-steroidal anti-inflammatory drugs | 23 (6.9) | 16 (6.3) | 98 (6.7) |
Any other relevant therapies* | 58 (17.5) | 47 (18.6) | 274 (18.8) |
Unknown | 8 (2.4) | 18 (7.1) | 120 (8.3) |